Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 27th July 2023 at 4.00 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EarningsAudioQ1-2023-24.mp3 Written transcript of the same will be submitted in due course.
27-07-2023
Bigul

AJANTA PHARMA LTD. - 532331 - Grant Of Options

 Nomination & Remuneration Committee meeting has at its meeting held today granted 76,350 options.
27-07-2023
Bigul

AJANTA PHARMA LTD. - 532331 - Corporate Action-Board approves Dividend

 Pursuant to Reg. 42 of SEBI LODR, the record date for the purpose of determination of dividend has been fixed as Friday, 4th August 2023
27-07-2023
Bigul

AJANTA PHARMA LTD. - 532331 - Corporate Action-Board approves Dividend

 Board had at their meeting held today considered and approved: 1. 1st interim dividend of Rs. 315 cr for FY 2024. It translates into Rs. 25 per share (1250%) on face-value of Rs. 2/- per share. Total dividend of Rs. 25 per share includes a regular dividend of Rs. 10 per share and an additional Rs. 15 per share, distributed as a special dividend on the commemoration of 50 years of momentous journey of the Company. 2. Fixed Friday, 4th August 2023 as the record date for payment of interim dividend and special dividend. Dividend will be paid on or after 11th August 2023.
27-07-2023
Bigul

AJANTA PHARMA LTD. - 532331 - Financial Results For Quarter Ended 30Th June 2023

 Enclosed Financial results for quarter ended 30th June 2023.
27-07-2023
Bigul

AJANTA PHARMA LTD. - 532331 - Board Meeting Outcome for Outcome Of Board Meeting

 Outcome of Board Meeting
27-07-2023
Bigul

AJANTA PHARMA LTD. - 532331 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 PFA herewith intimation w.r.t. loss of share certificates.
24-07-2023
Bigul

AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith the schedule of Earnings Conference Call to be held on 27th July 2023, post Board meeting.
24-07-2023
Bigul

AJANTA PHARMA LTD. - 532331 - Corporate Action-Board to consider Dividend

 Board to consider interim dividend at the meeting held on Thursday, 27th July 2023.
24-07-2023
Bigul

AJANTA PHARMA LTD. - 532331 - Update on board meeting

 AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 ,inter alia, to consider and approve This is with reference to our letter dated 14th July 2023, informing you about the Board meeting scheduled on Thursday, 27th July 2023 to inter-alia consider and take on record the unaudited financial results for the first quarter ended 30th June 2023. Pursuant to Regulation 29(1)(e) of Listing Regulations, we hereby inform you that, at the aforesaid Board Meeting, the Board of Directors will also consider proposal for: a. declaration of interim dividend, if any, for the financial year ending 31st March 2024; and b. fixation of Friday, 4th August 2023 as the Record Date for the payment of interim dividend, if declared.
24-07-2023
Next Page
Close

Let's Open Free Demat Account